Bronstein, Gewirtz & Grossman, LLC Encourages Orthofix Medical Inc. (OFIX) Investors to Inquire about Securities Investigation
Orthofix to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Orthofix to Participate in Upcoming Investor Conferences
OFIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Orthofix Medical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Orthofix Medical Inc. (NASDAQ: OFIX) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $22.00 price target on the stock, up previously from $20.00.